November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Aaron Goodman: 5-year follow-up of POLARIX
Nov 9, 2024, 15:35

Aaron Goodman: 5-year follow-up of POLARIX

Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared a post on X:

“5-year follow-up of POLARIX.

5 year PFS

  • P-RCHP = 64.2%
  • RCHOP = 59.1%

No significant difference in OS

  • P-RCHP = 82.2%
  • RCHOP = 79.6%

In 2024 for newly diagnosed advanced stage DLBCL what do you recommend for treatment?

  • RCHOP
  • Pola-RCHP
  • DA-EPOCH-R
  • Depends (GCB vs non-GCB).”

More posts featuring Aaron Goodman.

Aaron Goodman is a Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.